H1 vs. Citeline
H1 delivers comprehensive trial data plus global disease insights, deeper site intelligence, and leading-edge AI innovation—capabilities Citeline can’t match.
Trusted by 250+ leading companies
Trusted by over 60+ leading companies
Launch Your Trial Planning into the Future with H1
H1 gives you comprehensive global insights to enhance your trial planning capabilities. By incorporating global disease prevalence data, including rare diseases, and global claims data, H1 helps you align trial feasibility with actual geographic disease burden, enabling you to target the right sites and accelerate patient recruitment. H1 also offers global clinical identifiers, which standardize site and PI data worldwide. This comprehensive global intelligence gives you advantages Citeline simply can’t provide.
H1 provides CTMS performance metrics and enrollment rates that give you visibility into how sites actually perform. See which sites consistently meet enrollment targets and timelines, helping you select sites based on proven results. Additionally, H1 offers comprehensive site capabilities data including facility infrastructure and equipment, so you understand operational readiness before you commit. These site insights Citeline simply doesn’t offer.
H1 is rapidly evolving to meet modern trial challenges through our customer-influenced roadmap, ensuring new capabilities are always in development based on user needs. While legacy platforms like Citeline remain largely unchanged, H1 delivers continuous innovation. Our AI capabilities are included at no additional cost—unlike competitors who charge extra—so you can leverage AI to rapidly analyze datasets, accelerate trial planning, and forecast patient recruitment without hidden fees.
Launch Your Trial Planning into the Future with H1
H1 gives you a global edge in trial planning that Citeline can’t match. By incorporating global disease prevalence data, including rare diseases, and global claims data, H1 helps you align trial feasibility with real geographic disease burden so you target the right sites and accelerate patient recruitment. H1 also offers Global Clinical Identifiers (GCI), which standardize site and PI data worldwide.
H1 delivers actionable feasibility insights with interconnected data across sites, investigators, and patient populations: a view Citeline doesn’t show. By providing unmatched site analysis, H1 helps you minimize enrollment delays and fast-track new medicines to market. Don’t limit yourself to retrospective trial data. See feasibility criteria from both past and current trials with real-time intelligence that helps you expedite and optimize your site assessments.
While Citeline’s platform remains largely unchanged, H1 is rapidly evolving to meet modern trial challenges. Our customer-influenced roadmap ensures that new capabilities are always in development, driven by the real needs of trial sponsors like you. Unlike competitors who charge extra for AI functionality, H1’s AI capabilities are included at no additional cost. Our platform leverages AI to rapidly analyze datasets for faster trial planning and forecast patient recruitment at the site level.
Using Patient Population Data to Identify Sites for Rare Disease Trials
“When we look for sites now, we can go to the [H1] platform and we can put in the criteria that we know we’re looking for, such as using the ICD codes. And that allows us to find out immediately how many clinical trials we need.”
– Pamela Fearon, VP, Global Study Operations at BioMarin
H1 provides comprehensive global disease prevalence data, including rare diseases, plus global claims data and global clinical identifiers that standardize site and PI data worldwide. This real-world disease burden data helps you align your trial strategy with where patients actually are.
H1 provides CTMS performance metrics, enrollment rates, and detailed site capabilities data including facility infrastructure. This enhanced visibility into both performance history and operational readiness helps you select sites with confidence—data that Citeline simply doesn’t provide.
All of H1’s AI functionality is included at no additional cost. Our platform uses AI to rapidly analyze datasets for faster trial planning and patient recruitment forecasting. Unlike some competitors who restrict data access or charge extra fees, H1 gives you full access to leverage your data for machine learning initiatives.